bone marrow transplant

(redirected from Hematopoietic stem cell transplantation)
Also found in: Dictionary, Medical, Acronyms, Wikipedia.

bone marrow transplant:

see bone marrowbone marrow,
soft tissue filling the spongy interiors of animal bones. Red marrow is the principal organ that forms blood cells in mammals, including humans (see blood). In children, the bones contain only red marrow.
..... Click the link for more information.
References in periodicals archive ?
Table 9: Examples of conditioning regimens used in hematopoietic stem cell transplantation by type of hematologic malignancy 32
A review of the Hematopoietic Stem Cell Transplantation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
ASC-101 will potentially transform hematopoietic stem cell transplantation by accelerating patients' immune system and platelet recovery, reducing opportunistic infections and other co-morbidities, and possibly improving patient survival.
Baltimore, MD, has initiated a human clinical trial for Allogen in cancer patients receiving chemotherapy and hematopoietic stem cell transplantation for the treatment of high-risk hematological malignancies, including acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia and non-Hodgkin's lymphoma.
Hematopoietic stem cell transplantation is considered the treatment of choice for many patients with severe malignant or non-malignant, acquired or congenital disorders of the hematopoietic system or for patients with chemosensitive, radiosensitive or immunosensitive tumors.
The key focus indication for Kiadis Pharma is limitations and complications of hematopoietic stem cell transplantation procedures.
Cambridge, MA, announced it has successfully completed a Phase I clinical study on its proprietary small-molecule drug, AP1903, for use in the treatment of graft-versus-host disease (GvHD) in patients undergoing allogeneic bone marrow or hematopoietic stem cell transplantation (BMT).
Hematopoietic stem cell transplantation (HSCT) has evolved considerably over the past 50 years, driven by developments in stem cell sources, donor identification and conditioning regimens.
17] Therefore, the definitive treatment should be chemotherapy followed by hematopoietic stem cell transplantation.
A previous study found that autologous nonmyeloablative hematopoietic stem cell transplantation (HSCT) in 15 patients with newly diagnosed type 1 DM resulted in the majority of patients becoming insulin free during the follow-up, which averaged about 19 months.
Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem cell transplantation in the United States.
Hematopoietic stem cell transplantation is replacing the old fashioned bone marrow transplants.

Full browser ?